Fenbu Fen Jiaonang (芬布芬胶囊)芬布芬胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

批准文号:NMPA approval number: 国药准字H42021133

生产企业Manufacturer

药物知识说明

国药准字H42021133是一种在国家药监局注册认定的药品。标注生产企业为武汉同济现代医药科技股份有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:武汉同济现代医药科技股份有限公司Chinese legal name: 武汉同济现代医药科技股份有限公司、武汉同济现代医药科技股份有限公司Chinese legal name: 武汉同济现代医药科技股份有限公司、武汉同济现代医药科技股份有限公司Chinese legal name: 武汉同济现代医药科技股份有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 芬布芬胶囊) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 武汉同济现代医药科技股份有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 武汉同济现代医药科技股份有限公司Chinese legal name: 武汉同济现代医药科技股份有限公司, 武汉同济现代医药科技股份有限公司Chinese legal name: 武汉同济现代医药科技股份有限公司, 武汉同济现代医药科技股份有限公司Chinese legal name: 武汉同济现代医药科技股份有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 芬布芬胶囊Recorded Chinese name: 芬布芬胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 0.15g×10片。0.15 g × 10 tablets。

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 武汉同济现代医药科技股份有限公司Chinese legal name: 武汉同济现代医药科技股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H42021133

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H42021133

Manufacturer

Chinese legal name: 武汉同济现代医药科技股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

0.15 g × 10 tablets。

中文说明书原文Original Chinese source label

批准文号

国药准字H42021133

生产企业

武汉同济现代医药科技股份有限公司(国产)

适应症

1.本品用于类风湿关节炎,风湿性关节炎,骨关节炎,脊柱关节病的治疗。|2.还可用于牙痛,手术后疼痛及外伤性疼痛。

用法用量

口服。|1.成人常用量:一日0.6g,1次或分2次服用。成人一日总量不超过1.0g。|2.小儿常用量:尚未建立。

不良反应

1.本品不良反应主要为胃肠道反应,表现为胃痛、胃烧灼感、恶心,少数出现严重不良反应包括胃溃疡、出血、甚至穿孔。|2.头晕、皮疹、白细胞数轻度下降、血清转移酶微升等较少见。

禁忌

1.对本品过敏者禁用。|2.消化性溃疡、严重肝肾功能损害、阿司匹林引起哮喘者禁用。|3.孕妇、哺乳期妇女及儿童应禁用。

注意事项

同其他非甾体抗炎药有交叉过敏反应。

贮藏

遮光,密封保存。

规格

0.15g×10片。

证据Evidence

  • 批准文号: 国药准字H42021133
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.